Comment on

• High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.

  Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR, Fink NE, Levey AS, Coresh J. Longenecker JC, et al. J Am Soc Nephrol. 2005 Jun;16(6):1794-802. doi: 10.1681/ASN.2004110922. Epub 2005 Mar 30. J Am Soc Nephrol. 2005. PMID: 15800123
• Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.

  Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH. Deicher R, et al. J Am Soc Nephrol. 2005 Jun;16(6):1811-8. doi: 10.1681/ASN.2004100850. Epub 2005 Apr 6. J Am Soc Nephrol. 2005. PMID: 15814831
• Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.

  Slinin Y, Foley RN, Collins AJ. Slinin Y, et al. J Am Soc Nephrol. 2005 Jun;16(6):1788-93. doi: 10.1681/ASN.2004040275. Epub 2005 Apr 6. J Am Soc Nephrol. 2005. PMID: 15814832